Irritable Bowel Syndrome With Constipation Poses a Substantial Burden to Patient Overall Health Status and Quality of Life: Results From the IBS in America 2024 Real-World Survey.
出版信息
Gastroenterol Hepatol (N Y). 2024 Dec;20(12 Suppl 9):2-3.
Abstract
摘要
相似文献
1
Irritable Bowel Syndrome With Constipation Poses a Substantial Burden to Patient Overall Health Status and Quality of Life: Results From the IBS in America 2024 Real-World Survey.便秘型肠易激综合征对患者整体健康状况和生活质量构成重大负担：2024年美国肠易激综合征真实世界调查结果
Gastroenterol Hepatol (N Y). 2024 Dec;20(12 Suppl 9):2-3.
2
Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype.与鲁比前列酮治疗肠易激综合征便秘亚型相关的治疗模式、症状减轻、生活质量及资源利用情况
Curr Med Res Opin. 2016 May;32(5):899-905. doi: 10.1185/03007995.2016.1150262. Epub 2016 Mar 11.
3
Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.腹泻型肠易激综合征患者的疾病特异性生活质量低于便秘型肠易激综合征患者。
World J Gastroenterol. 2015 Jul 14;21(26):8103-9. doi: 10.3748/wjg.v21.i26.8103.
4
Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR).使用确定性链接的行政索赔和患者报告数据对便秘型肠易激综合征和慢性特发性便秘患者进行综合评估：慢性便秘和肠易激综合征 C 型治疗和结局真实世界研究平台（CONTOR）。
J Med Econ. 2020 Oct;23(10):1072-1083. doi: 10.1080/13696998.2020.1799816. Epub 2020 Aug 11.
5
A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.一项针对西班牙中重度便秘型肠易激综合征社会经济负担的回顾性和前瞻性12个月观察性研究。
Gastroenterol Hepatol. 2019 Mar;42(3):141-149. doi: 10.1016/j.gastrohep.2018.10.008. Epub 2019 Jan 3.
6
A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.肠易激综合征和慢性便秘疾病经济负担及人文负担的系统评价
J Manag Care Pharm. 2013 Nov-Dec;19(9):755-64. doi: 10.18553/jmcp.2013.19.9.755.
7
The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden.以便秘为主的肠易激综合征和慢性特发性便秘的范围：美国评估症状、就医情况和疾病负担的调查
Am J Gastroenterol. 2015 Apr;110(4):580-7. doi: 10.1038/ajg.2015.67. Epub 2015 Mar 17.
8
Information- and Health-care Seeking Behaviors in Patients With Irritable Bowel Syndrome.肠易激综合征患者的信息和医疗保健寻求行为。
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2840-2842. doi: 10.1016/j.cgh.2019.09.020. Epub 2019 Sep 20.
9
Recent advances in pharmacological treatment of irritable bowel syndrome.肠易激综合征药物治疗的最新进展
World J Gastroenterol. 2014 Jul 21;20(27):8867-85. doi: 10.3748/wjg.v20.i27.8867.
10
Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire.更好地理解和认识便秘型肠易激综合征（BURDEN IBS-C）患者的脱节、体验和需求研究：在线问卷结果。
Adv Ther. 2018 Jul;35(7):967-980. doi: 10.1007/s12325-018-0733-x. Epub 2018 Jun 26.
引用本文的文献
1
Patient-Centered Approach in IBS-C Management.肠易激综合征便秘型管理中的以患者为中心的方法
Gastroenterol Hepatol (N Y). 2025 Jun;21(6):362-373.
2
Raising Expectations in IBS-C Management.提高IBS-C管理的期望。
Gastroenterol Hepatol (N Y). 2025 Apr;21(4):218-231.
Zotero 插件